Dr. Angela Winegar serves as the Senior Director of Health Economics and Clinical Effectiveness within the Ascension Data Sciences Institute, an organization that supports Ascension’s 151 hospitals and approximately 34,000 employed and affiliated healthcare providers. Her team, which consists of analysts and data scientists, applies machine learning techniques to decrease unwarranted clinical variation and deliver more reliable, cost-effective care. To prepare Ascension for the expected move to value-based reimbursement models, Dr. Winegar leads efforts to develop balanced service-line reports. These track acute-care and ambulatory quality, financial data, growth, and operational efficiency performance; they are risk adjusted to account for heterogeneity within the patient population. Additionally, she partners with clinician leaders to conduct large-scale, real-world clinical effectiveness studies, made possible by pulling in data from Ascension’s standard cost accounting system, clinical registries and soon, claims data. Dr.
Winegar has more than 15 years of experience supporting the healthcare industry, including pharmaceutical, biotechnology and medical device manufacturers, as well as large provider organizations. Her success in engaging and communicating with physicians to translate analytic output into meaningful care improvement opportunities has resulted in several peer-reviewed publications. Dr. Winegar earned her undergraduate degree in molecular biology from Princeton University and her doctoral degree in health economics and outcomes from the University of Texas College of Pharmacy in Austin. She serves as affiliate faculty for the department of surgery and perioperative care at the Dell Medical School at the University of Texas at Austin.